Publications

Pour rechercher une publication scientifique, insérez vos mots-clés en anglais.

Genomic Microevolution of Vibrio cholerae O1, Lake Tanganyika Basin, Africa.

Abstract

Africa's Lake Tanganyika basin is a cholera hotspot. During 2001-2020, Vibrio cholerae O1 isolates obtained from the Democratic Republic of the Congo side of the lake belonged to 2 of the 5 clades of the AFR10 sublineage.

Hounmanou YMG Njamkepo E Rauzier J Gallandat K Jeandron A Kamwiziku G Porten K Luquero F Abedi AA Rumedeka BB Miwanda B Michael M Okitayemba PW Saidi JM Piarroux R Weill FX Dalsgaard A Quilici ML
Emerging infectious diseases 2023 Jan ; 29(1); . doi: 10.3201/eid2901.220641. Epub 2022 12 28
Africa. Emerg Infect Dis. 2023 Jan [date cited]. https://doi.org/10.3201/eid2901.220641 African Great Lakes Region Burundi Democratic Republic of Congo Gallandat K Jeandron A Kamwiziku G Lake Tanganyika Lake Tanganyika Basin Njamkepo E Rauzier J Suggested citation for this article: Hounmanou YMG Tanzania Vibrio cholerae Zambia bacteria cholera et al. Genomic microevolution of Vibrio cholerae O1 genomics neglected tropical diseases

Plasmodium infection is associated with cross-reactive antibodies to carbohydrate epitopes on the SARS-CoV-2 Spike protein.

Abstract

Sero-surveillance can monitor and project disease burden and risk. However, SARS-CoV-2 antibody test results can produce false positive results, limiting their efficacy as a sero-surveillance tool.

Sarah Lapidus Feimei Liu Arnau Casanovas-Massana Yile Dai John D. Huck Carolina Lucas et al.
Sci Rep. 2022; 12: 22175. Published online 2022 Dec 22. doi: 10.1038/s41598-022-26709-7
Malaria Infectious-disease diagnostics Viral infection

Snakebite envenoming at MSF: A decade of clinical challenges and antivenom access issues.

Abstract

The medical humanitarian organization Médecins Sans Frontières (MSF) provides medical care in more than 70 countries and admits more than 7000 cases of snakebite in its facilities each year.

Julien Potet Saschveen Singh Koert Ritmeijer Kasaye Sisay Gabriel Alcoba Fabienne Jouberton et al.
Toxicon: X. Volume 17, March 2023, 100146. Published online 2022 Dec 21. doi: 10.1016/j.toxcx.2022.100146
snakebite Antivenoms

Effect of systematic tuberculosis detection on mortality in young children with severe pneumonia in countries with high incidence of tuberculosis: a stepped-wedge cluster-randomised trial.

Abstract

BACKGROUND: Tuberculosis diagnosis might be delayed or missed in children with severe pneumonia because this diagnosis is usually only considered in cases of prolonged symptoms or antibiotic failure.

Marcy O Wobudeya E Font H Vessière A Chabala C Khosa C Taguebue JV Moh R Mwanga-Amumpaire J Lounnas M Mulenga V Mavale S Chilundo J Rego D Nduna B Shankalala P Chirwa U De Lauzanne A Dim B Tiogouo Ngouana E Folquet Amorrissani M Cisse L Amon Tanoh Dick F Komena EA Kwedi Nolna S Businge G Natukunda N Cumbe S Mbekeka P Kim A Kheang C Pol S Maleche-Obimbo E Seddon JA Mao TE Graham SM Delacourt C Borand L Bonnet M
The Lancet. Infectious diseases 2022 Nov 14; . doi: 10.1016/S1473-3099(22)00668-5. Epub 2022 11 14

Selection bias in multidrug-resistant tuberculosis cohort studies assessing sputum culture conversion.

Abstract

BACKGROUND: Conversion of sputum culture from positive to negative for M. tuberculosis is a key indicator of treatment response. An initial positive culture is a pre-requisite to observe conversion.

Rodriguez CA Lodi S Horsburgh CR Bastard M Hewison C Huerga H Khan M Khan PY Khan U Oyewusi L Padayachee S Mitnick CD Franke MF
PloS one 2022 ; 17(11); . doi: 10.1371/journal.pone.0276457. Epub 2022 11 10

Differential symptomology of possible and confirmed Ebola virus disease infection in the Democratic Republic of the Congo: a retrospective cohort study.

Abstract

BACKGROUND: In its earliest phases, Ebola virus disease's rapid-onset, high fever, and gastrointestinal symptoms are largely indistinguishable from other infectious illnesses.

Nsio J Ardiet DL Coulborn RM Grellety E Albela M Grandesso F Kitenge R Ngwanga DL Matady B Manangama G Mossoko M Ngwama JK Mbala P Luquero F Porten K Ahuka-Mundeke S
The Lancet. Infectious diseases 2022 Nov 09; . doi: 10.1016/S1473-3099(22)00584-9. Epub 2022 11 09

Intensified tuberculosis treatment to reduce the mortality of HIV-infected and uninfected patients with tuberculosis meningitis (INTENSE-TBM): study protocol for a phase III randomized controlled trial.

Abstract

BACKGROUND: Tuberculous meningitis (TBM) is the most lethal and disabling form of tuberculosis (TB), particularly in sub-Saharan Africa.

Maitre T Bonnet M Calmy A Raberahona M Rakotoarivelo RA Rakotosamimanana N Ambrosioni J Miró JM Debeaudrap P Muzoora C Davis A Meintjes G Wasserman S Wilkinson R Eholié S Nogbou FE Calvo-Cortes MC Chazallon C Machault V Anglaret X Bonnet F
Trials 2022 Nov 08; 23(1); . doi: 10.1186/s13063-022-06772-1. Epub 2022 11 08
Aspirin HIV, High-dose rifampicin Linezolid Randomized controlled trial Tuberculous meningitis
Hodson DZ Mbarga Etoundi Y Mbatou Nghokeng N Mohamadou Poulibe R Magne Djoko S Goodwin J Cheteug Nguesta G Nganso T Armstrong JN Andrews JJ Zhang E Wade M Eboumbou Moukoko CE Boum Y Parikh S
Malaria journal 2022 Oct 22; 21(1); . doi: 10.1186/s12936-022-04315-2. Epub 2022 10 22
Anaemia Cameroon Douala Febrile illness Malaria Plasmodium falciparum Urban